DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▼ |
---|---|---|---|---|---|
C0006142 | Malignant neoplasm of breast | GALNT5 | 11227 | polypeptide N-acetylgalactosaminyltransferase 5 | Q7Z7M9 |
C0006826 | Malignant Neoplasms | GALNT5 | 11227 | polypeptide N-acetylgalactosaminyltransferase 5 | Q7Z7M9 |
C0027651 | Neoplasms | GALNT5 | 11227 | polypeptide N-acetylgalactosaminyltransferase 5 | Q7Z7M9 |
C0699791 | Stomach Carcinoma | GALNT5 | 11227 | polypeptide N-acetylgalactosaminyltransferase 5 | Q7Z7M9 |
C0235974 | Pancreatic carcinoma | GALNT5 | 11227 | polypeptide N-acetylgalactosaminyltransferase 5 | Q7Z7M9 |
C1335302 | Pancreatic Ductal Adenocarcinoma | GALNT5 | 11227 | polypeptide N-acetylgalactosaminyltransferase 5 | Q7Z7M9 |
C1306459 | Primary malignant neoplasm | GALNT5 | 11227 | polypeptide N-acetylgalactosaminyltransferase 5 | Q7Z7M9 |
C0024623 | Malignant neoplasm of stomach | GALNT5 | 11227 | polypeptide N-acetylgalactosaminyltransferase 5 | Q7Z7M9 |
C0007102 | Malignant tumor of colon | B3GNT8 | 374907 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 | Q7Z7M8 |
C0699790 | Colon Carcinoma | B3GNT8 | 374907 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 | Q7Z7M8 |
C0009375 | Colonic Neoplasms | B3GNT8 | 374907 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 | Q7Z7M8 |
C0206698 | Cholangiocarcinoma | VTCN1 | 79679 | V-set domain containing T cell activation inhibitor 1 | Q7Z7D3 |
C0015934 | Fetal Growth Retardation | VTCN1 | 79679 | V-set domain containing T cell activation inhibitor 1 | Q7Z7D3 |
C1306459 | Primary malignant neoplasm | VTCN1 | 79679 | V-set domain containing T cell activation inhibitor 1 | Q7Z7D3 |
C0346647 | Malignant neoplasm of pancreas | VTCN1 | 79679 | V-set domain containing T cell activation inhibitor 1 | Q7Z7D3 |
C0027651 | Neoplasms | VTCN1 | 79679 | V-set domain containing T cell activation inhibitor 1 | Q7Z7D3 |
C0007137 | Squamous cell carcinoma | VTCN1 | 79679 | V-set domain containing T cell activation inhibitor 1 | Q7Z7D3 |
C0006142 | Malignant neoplasm of breast | VTCN1 | 79679 | V-set domain containing T cell activation inhibitor 1 | Q7Z7D3 |
C1332977 | Childhood Leukemia | VTCN1 | 79679 | V-set domain containing T cell activation inhibitor 1 | Q7Z7D3 |
C4048328 | cervical cancer | VTCN1 | 79679 | V-set domain containing T cell activation inhibitor 1 | Q7Z7D3 |
C0302592 | Cervix carcinoma | VTCN1 | 79679 | V-set domain containing T cell activation inhibitor 1 | Q7Z7D3 |
C0678222 | Breast Carcinoma | VTCN1 | 79679 | V-set domain containing T cell activation inhibitor 1 | Q7Z7D3 |
C1140680 | Malignant neoplasm of ovary | VTCN1 | 79679 | V-set domain containing T cell activation inhibitor 1 | Q7Z7D3 |
C0278878 | Adult Glioblastoma | VTCN1 | 79679 | V-set domain containing T cell activation inhibitor 1 | Q7Z7D3 |
C0235974 | Pancreatic carcinoma | VTCN1 | 79679 | V-set domain containing T cell activation inhibitor 1 | Q7Z7D3 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024